Cost-effectiveness of three internet-based interventions for eating disorders: A randomized controlled trial.

cost-benefit analysis cost-effectiveness eHealth eating disorders economic evaluation expert patient internet-based intervention quality of life randomized controlled trial

Journal

The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226

Informations de publication

Date de publication:
08 2022
Historique:
revised: 08 06 2022
received: 15 02 2022
accepted: 10 06 2022
pubmed: 25 6 2022
medline: 4 8 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

The primary aim was assessing the cost-effectiveness of an internet-based self-help program, expert-patient support, and the combination of both compared to a care-as-usual condition. An economic evaluation from a societal perspective was conducted alongside a randomized controlled trial. Participants aged 16 or older with at least mild eating disorder symptoms were randomly assigned to four conditions: (1) Featback, an online unguided self-help program, (2) chat or e-mail support from a recovered expert patient, (3) Featback with expert-patient support, and (4) care-as-usual. After a baseline assessment and intervention period of 8 weeks, five online assessments were conducted over 12 months of follow-up. The main result constituted cost-utility acceptability curves with quality-of-life adjusted life years (QALYs) and societal costs over the entire study duration. No significant differences between the conditions were found regarding QALYs, health care costs and societal costs. Nonsignificant differences in QALYs were in favor of the Featback conditions and the lowest societal costs per participant were observed in the Featback only condition (€16,741) while the highest costs were seen in the care-as-usual condition (€28,479). The Featback only condition had the highest probability of being efficient compared to the alternatives for all acceptable willingness-to-pay values. Featback, an internet-based unguided self-help intervention, was likely to be efficient compared to Featback with guidance from an expert patient, guidance alone and a care-as-usual condition. Results suggest that scalable interventions such as Featback may reduce health care costs and help individuals with eating disorders that are currently not reached by other forms of treatment. Internet-based interventions for eating disorders might reach individuals in society who currently do not receive appropriate treatment at low costs. Featback, an online automated self-help program for eating disorders, was found to improve quality of life slightly while reducing costs for society, compared to a do-nothing approach. Consequently, implementing internet-based interventions such as Featback likely benefits both individuals suffering from an eating disorder and society as a whole.

Identifiants

pubmed: 35748112
doi: 10.1002/eat.23763
pmc: PMC9546196
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1155

Informations de copyright

© 2022 The Authors. International Journal of Eating Disorders published by Wiley Periodicals LLC.

Références

Trials. 2019 Aug 16;20(1):509
pubmed: 31420063
Psychol Med. 2015 Dec;45(16):3357-76
pubmed: 26235445
Curr Psychiatry Rep. 2016 Apr;18(4):42
pubmed: 26946513
Value Health. 2015 Sep;18(6):753-8
pubmed: 26409601
Behav Res Ther. 2014 Dec;63:122-31
pubmed: 25461787
Eur Eat Disord Rev. 2021 May;29(3):329-345
pubmed: 32578311
Multivariate Behav Res. 2014 Jan 1;49(1):78-91
pubmed: 24860197
Int J Eat Disord. 2017 Mar;50(3):239-249
pubmed: 28152200
J Consult Clin Psychol. 2020 Nov;88(11):994-1007
pubmed: 32852971
Value Health. 2022 Jan;25(1):125-132
pubmed: 35031091
Qual Life Res. 2021 Mar;30(3):647-673
pubmed: 33284428
Curr Opin Psychiatry. 2013 Nov;26(6):543-8
pubmed: 24060914
PLoS One. 2017 Nov 9;12(11):e0187477
pubmed: 29121647
Eur Eat Disord Rev. 2012 Sep;20(5):410-3
pubmed: 22678930
Curr Opin Psychiatry. 2020 Nov;33(6):521-527
pubmed: 32796186
Int J Eat Disord. 1993 May;13(4):369-84
pubmed: 8490639
Qual Life Res. 2012 Feb;21(1):167-76
pubmed: 21598064
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Prev Med Rep. 2014 Dec 13;2:32-4
pubmed: 26844048
Depress Anxiety. 2018 Mar;35(3):209-219
pubmed: 29329486
Int J Eat Disord. 2016 Dec;49(12):1068-1076
pubmed: 27441418
Value Health. 2020 Apr;23(4):515-526
pubmed: 32327169
Int J Eat Disord. 2022 Aug;55(8):1143-1155
pubmed: 35748112
J Affect Disord. 2018 Jan 1;225:733-755
pubmed: 28922737
Qual Life Res. 2022 Mar;31(3):687-696
pubmed: 34463861
Patient Educ Couns. 2020 May;103(5):1033-1040
pubmed: 31836249
Behav Res Ther. 2009 Jun;47(6):451-3
pubmed: 19356743
Curr Opin Psychiatry. 2016 Nov;29(6):346-53
pubmed: 27532942
Eat Weight Disord. 2016 Sep;21(3):353-364
pubmed: 26942768
BMC Res Notes. 2018 Oct 22;11(1):748
pubmed: 30348226
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64
pubmed: 23252357
Int J Eat Disord. 2017 Mar;50(3):250-258
pubmed: 28152203
Int J Eat Disord. 2016 Jan;49(1):19-31
pubmed: 26607683
Arch Gen Psychiatry. 2011 Jul;68(7):724-31
pubmed: 21727255
Prev Sci. 2021 Nov;22(8):1086-1095
pubmed: 34152570
Value Health. 2015 Dec;18(8):994-9
pubmed: 26686783
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):25-41
pubmed: 29145746
J Med Internet Res. 2016 Jun 17;18(6):e159
pubmed: 27317358
Int J Eat Disord. 2018 Feb;51(2):155-164
pubmed: 29345848
J Clin Psychiatry. 2018 Jan/Feb;79(1):
pubmed: 29228517
Value Health. 2016 Jun;19(4):343-52
pubmed: 27325326
Behav Res Ther. 2017 Jan;88:49-64
pubmed: 28110676
Clin Psychol Rev. 2011 Jul;31(5):727-35
pubmed: 21501580

Auteurs

Pieter J Rohrbach (PJ)

GGZ Rivierduinen Eetstoornissen Ursula, Leiden, Netherlands.
Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands.

Alexandra E Dingemans (AE)

GGZ Rivierduinen Eetstoornissen Ursula, Leiden, Netherlands.

Eric F van Furth (EF)

GGZ Rivierduinen Eetstoornissen Ursula, Leiden, Netherlands.
Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands.

Philip Spinhoven (P)

Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands.
Institute of Psychology, Leiden University, Leiden, Netherlands.

Joost R van Ginkel (JR)

Institute of Psychology, Leiden University, Leiden, Netherlands.

Stephanie Bauer (S)

Center for Psychotherapy Research, University of Heidelberg, Heidelberg, Germany.

M Elske van den Akker-Van Marle (ME)

Department of Biomedical Sciences Section Medical Decision Making, Leiden University Medical Center, Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH